Showing results (11-20 of 226) with videos related to
Sort By:
Pageof 23
British Journal of Cancer|December 1, 1988
Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervixG J Rustin, E S NewlandsMedical Oncology and Tumor Pharmacotherapy|January 1, 1987
Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancerI F Adewole, E S NewlandsThe Journal of Reproductive Medicine|February 25, 1998
Gestational trophoblastic disease. Molecular and genetic studiesR A Fisher, E S NewlandsTransplantation|July 1, 1975
Evidence for two cell populations involved in the rejection of a xenograft in miceE S Newlands, I M RoittCancer Chemotherapy and Pharmacology|January 1, 1982
The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinomaE S Newlands, K D BagshaweJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Cancer Research Campaign phase II trial of temozolomide in metastatic melanomaN M Bleehen, E S Newlands, S M Lee, et al.British Journal of Cancer|July 17, 2003
Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomasE S Newlands, T Foster, S ZaknoenClinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapyM Bower, E S Newlands, N HabibBritish Journal of Cancer|January 1, 1986
Plasma and tissue disposition of mitozolomide in miceC J Brindley, P Antoniw, E S NewlandsThe International Journal of Biological Markers|July 1, 1988
Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs)E S Newlands, L Holden, K D BagshawePageof 23